This $2,419,326 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study to investigate neurobehavioral and psychosocial predictors of health risk behaviors (HRBs) in adolescence and young adulthood. The primary awardee, Virginia Polytechnic Institute & State University, will conduct assessments over 15 years to understand brain development and its impact on substance use and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to study the neurogenetic mechanisms underlying nicotine and cannabis addiction. The $175,888 award, effective September 1, 2024 through August 31, 2028, will enable the development of novel transcriptome-connectome analysis methods to identify genes associated with changes in brain functional connectivity related to addiction. The...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Scripps Research Institute provides $288,107 in funding from July 1, 2025 to June 30, 2030. The grant supports a predoctoral training program to develop a new generation of leaders in addiction research, equipped with technical skills and expertise in team science to translate research targets into potential treatments. The program combines a core of expert mentors...
This $181,040 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to create an immersive training experience to study the genetic etiology of substance use disorders (SUDs). The award recipient, Yale University, will leverage the Million Veteran Program (MVP) biobank to: (1) model patterns of SUD co-occurrence and substance co-use, (2) utilize electronic health record data and toxicology results to provide...
This federal Project Grant award of $840,425.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research examining the impact of prenatal and postnatal substance exposure on adolescent risk behaviors. The award to The Pennsylvania State University will leverage a longitudinal sample of 247 families to investigate developmental cascades linking pre- and post-natal substance use risks to adolescent substance use,...
This Project Grant award of $1,838,237, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the neuronal circuits through which chronic stress promotes habit formation. The award, effective September 15, 2024 and ending May 31, 2029, will be executed by the University of California, Los Angeles (UCLA). The research aims to expose how opposing amygdala-striatal pathways in the brain enable...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This Project Grant award of $250,568.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a 3-year research project to investigate the neurobiological mechanisms underlying individual and sex differences in emotional cue processing related to addiction and post-traumatic stress disorder. The award recipient, the Regents of the University of Michigan, will use chemogenetic and fiber photometry techniques to gain control...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $423,447 to Brown University to investigate the impact of social-contextual stressors on smoking cessation and relapse among socioeconomically disadvantaged young adults (SDYA) who smoke cigarettes. The research aims to gain an in-depth understanding of how social-contextual stressors affect smoking cessation and relapse in SDYA through a...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $257,522 Project Grant (R25DA061764) to the University of Mississippi to develop a multimodal and interdisciplinary data science training program. The program aims to enhance a diverse workforce for addiction research by providing specialized training in artificial intelligence (AI) and machine learning (ML) methods. Key program components include webinars, summer...